Spots Global Cancer Trial Database for basal cell nevus syndrome
Every month we try and update this database with for basal cell nevus syndrome cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome | NCT03767439 | Basal Cell Nevu... | Vismodegib Nivolumab Ipilimumab | 18 Years - | Columbia University | |
| To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) | NCT00957229 | Basal Cell Nevu... Gorlin Syndrome | GDC-0449 | 35 Years - 75 Years | UCSF Benioff Children's Hospital Oakland | |
| Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS) | NCT03208296 | Basal Cell Carc... | ASN-002 | 18 Years - | Ascend Biopharmaceuticals Ltd | |
| Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome | NCT02157623 | Basal Cell Nevu... | Levulan Red Light PDT Blue Light PDT | - | The Cleveland Clinic | |
| An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC | NCT04155190 | Recurrent Basal... | Patidegib Topic... Patidegib Topic... | 18 Years - | Sol-Gel Technologies, Ltd. | |
| Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas | NCT01556009 | Basal Cell Nevu... Gorlin's Syndro... | Vismodegib Aminolevulinic ... | 18 Years - 75 Years | UCSF Benioff Children's Hospital Oakland | |
| Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer | NCT01463709 | Basal Cell Carc... | PulseCure pulse... | 18 Years - 75 Years | UCSF Benioff Children's Hospital Oakland | |
| Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients | NCT02762084 | Basal Cell Nevu... | Patidegib Vehicle gel | 18 Years - 85 Years | PellePharm, Inc. | |
| An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC | NCT04155190 | Recurrent Basal... | Patidegib Topic... Patidegib Topic... | 18 Years - | Sol-Gel Technologies, Ltd. | |
| Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma | NCT03467789 | Basal Cell Carc... Basal Cell Nevu... | Dietary Vitamin... Photodynamic th... Serum Maintenan... | - | Case Comprehensive Cancer Center | |
| Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) | NCT03070691 | Basal Cell Carc... | LDE225B Vehicle | 18 Years - | Novartis | |
| Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling | NCT06330350 | Quality of Life Ichthyosis Palmoplantar Ke... Epidermolysis B... Ectodermal Dysp... Basal Cell Nevu... Birt-Hogg-Dube ... Tuberous Sclero... Cutis Laxa Albinism | Qualitative int... | - | Maastricht University Medical Center | |
| Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome) | NCT04308395 | Basal Cell Nevu... | Patidegib Topic... | 18 Years - | Sol-Gel Technologies, Ltd. | |
| Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma | NCT02303041 | Carcinoma, Basa... Recurrent Skin ... Skin Neoplasms Basal Cell Nevu... | Buparlisib Sonidegib | 18 Years - | Stanford University | |
| Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study | NCT05463757 | Basal Cell Carc... Locally Advance... Metastatic Basa... Gorlin Syndrome Basal Cell Nevu... Carcinoma, Basa... Carcinoma Basal Cell Tumo... Skin Cancer Neoplasm of Ski... Neoplasms, Basa... | Vismodegib Sonidegib | - | Maastricht University Medical Center | |
| Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome | NCT03767439 | Basal Cell Nevu... | Vismodegib Nivolumab Ipilimumab | 18 Years - | Columbia University | |
| Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) | NCT03703310 | Basal Cell Nevu... | Patidegib Topic... Patidegib Topic... | 18 Years - | PellePharm, Inc. | |
| Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling | NCT06330350 | Quality of Life Ichthyosis Palmoplantar Ke... Epidermolysis B... Ectodermal Dysp... Basal Cell Nevu... Birt-Hogg-Dube ... Tuberous Sclero... Cutis Laxa Albinism | Qualitative int... | - | Maastricht University Medical Center | |
| Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome | NCT02157623 | Basal Cell Nevu... | Levulan Red Light PDT Blue Light PDT | - | The Cleveland Clinic | |
| Reproductive Options in Inherited Skin Diseases | NCT06330324 | Ichthyosis Palmoplantar Ke... Epidermolysis B... Ectodermal Dysp... Basal Cell Nevu... Birt-Hogg-Dube ... Tuberous Sclero... Xeroderma Pigme... Cutis Laxa Albinism | - | Maastricht University Medical Center | ||
| Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome | NCT02100371 | Basal Cell Nevu... | BMS-833923 | 18 Years - | University Health Network, Toronto | |
| Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS) | NCT03208296 | Basal Cell Carc... | ASN-002 | 18 Years - | Ascend Biopharmaceuticals Ltd | |
| To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) | NCT00957229 | Basal Cell Nevu... Gorlin Syndrome | GDC-0449 | 35 Years - 75 Years | UCSF Benioff Children's Hospital Oakland | |
| A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma | NCT02550678 | Basal Cell Nevu... Skin Neoplasm Nodular Basal C... | ASN-002 5-FU | 18 Years - | Ascend Biopharmaceuticals Ltd | |
| Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma | NCT03467789 | Basal Cell Carc... Basal Cell Nevu... | Dietary Vitamin... Photodynamic th... Serum Maintenan... | - | Case Comprehensive Cancer Center | |
| Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome) | NCT04308395 | Basal Cell Nevu... | Patidegib Topic... | 18 Years - | Sol-Gel Technologies, Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
